KPL-914-C002- A Phase 3, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study With Open-Label Extension, To Assess The Efficacy And Safety Of Rilonacept Treatment In Subjects With Recurrent Pericarditis. (RHAPSODY)

Nicholls, Stephen (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

NMA HREC Reference Number: HREC/48510/MonH-2019-162416(v1)
NMA SSA Reference Number: SSA/48510/MonH-2019-162927(v1)
Monash Health Ref: RES-19-0000035A

Status	Active
Effective start/end date	3/06/19 → 2/06/24

View all

View less

Keywords

clinical trial
treatment efficacy
pericarditis
clinical trial
treatment efficacy
pericarditis
clinical trial
treatment efficacy
pericarditis